In tumors, studies have found that the NEK2 expression increases in a variety of tumors, and NEK2 promotes tumor growth, metastasis, drug resistance and other processes, including breast cancer, lung cancer, colorectal cancer, etc. [7–9]. Here, NEK2 is linked to lung cancer.